Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cover test

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    196 result(s) found for: Cover test. Displaying page 1 of 10.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2020-002515-21 Sponsor Protocol Number: D9612C09998 Start Date*: 2021-11-11
    Sponsor Name:AstraZeneca AB
    Full Title: "A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years of Age"
    Medical condition: Erosive Esophagitis
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10063657 Erosive esophagitis LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: ES (Temporarily Halted) BE (Trial now transitioned) GR (Trial now transitioned) LT (Trial now transitioned) PT (Trial now transitioned) IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2007-006776-11 Sponsor Protocol Number: 07ct/am06perm Start Date*: 2008-02-20
    Sponsor Name:gepepharm GmbH
    Full Title: Investigation of the local tolerability of pedimitex Lösung 0.5% - a permethrin containing solution - in 100 patients with head lice infection of both gender
    Medical condition: The product is intended to be used by patients suffering from head lice infestation.
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-001999-12 Sponsor Protocol Number: 1160.53 Start Date*: 2006-03-14
    Sponsor Name:Boehringer Ingelheim Ltd.
    Full Title: A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute sy...
    Medical condition: Acute symptomatic venous thromboembolism (VTE), i.e. uni- or bilateral deep vein thrombosis (DVT) of the leg involving proximal veins, and/or pulmonary embolism (PE) confirmed by definitive objecti...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) FI (Completed) SE (Completed) DK (Completed) AT (Completed) BE (Completed) ES (Completed) HU (Completed) CZ (Completed) PT (Completed) GR (Completed) IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002051-13 Sponsor Protocol Number: PANN3006 Start Date*: 2005-08-17
    Sponsor Name:Imperial College, London
    Full Title: A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopy
    Medical condition: Abnormal uterine bleeding (hysteroscopy to investigate and treatment of abnormal uterine bleeding)
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2020-000195-38 Sponsor Protocol Number: D3252C00004 Start Date*: 2020-11-18
    Sponsor Name:AstraZeneca AB
    Full Title: A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab for the Prevention of Recurrence of Nasal Polyps Following Surgical Rem...
    Medical condition: Nasal polyposis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10028754 Nasal polyp LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) BE (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-003213-98 Sponsor Protocol Number: LFCN_1-1_20160802 Start Date*: 2016-10-14
    Sponsor Name:Dep. Anaesthesia and Intensive Care, Aarhus University Hospital
    Full Title: The lateral femoral cutaneous nerve – description of the sensory territory and a novel ultrasound guided nerve block technique
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004865 10036236 Postoperative pain relief LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-004199-12 Sponsor Protocol Number: RG_11-139vitd Start Date*: 2012-01-04
    Sponsor Name:University of Birmingham
    Full Title: An open label dose ranging study to optimise vitamin D levels prior to oesophagectomy
    Medical condition: perioperative inflammation in patients undergoing oesophagectomy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000695-40 Sponsor Protocol Number: Final Version 2, 7 June 2005 Start Date*: 2005-09-27
    Sponsor Name:University of Nottingham
    Full Title: A randomised trial of aminosalicylate withdrawal in patients with ulcerative colitis in established remission on combination treatment of azathioprine (or 6−mercaptopurine) and an aminosalicylate
    Medical condition: The medical condition is Ulcerative Colitis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-005095-17 Sponsor Protocol Number: EA041999 Start Date*: 2005-02-10
    Sponsor Name:Engelhard Arzneimittel GmbH & Co. KG
    Full Title: Randomised, double-blind, placebo-controlled, monocentric phase III study on the efficacy and safety of Lidocaine 8 mg Sore Throat Lozenges in patients with moderate to severe acute sore throat not...
    Medical condition: The study will be performed in patients suffering from acute sore throat not necessarily to be treated with antibiotics
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2017-004122-15 Sponsor Protocol Number: UF9889 Start Date*: 2018-03-13
    Sponsor Name:University Hospital of Montpellier
    Full Title: A randomized, double-blind, placebo-controlled trial comparing the efficacy and tolerance of sodium oxybate in patients affected with idiopathic hypersomnia.
    Medical condition: current idiopathic hypersomnia (ICSD-3)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-004307-40 Sponsor Protocol Number: ATN-106 Start Date*: 2022-01-31
    Sponsor Name:Octapharma AG
    Full Title: A multicentre, prospective, open-label, uncontrolled Phase 3 study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing sur...
    Medical condition: Congenital antithrombin deficiency
    Disease: Version SOC Term Classification Code Term Level
    23.0 100000004850 10083881 Antithrombin deficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Trial now transitioned) AT (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022034-88 Sponsor Protocol Number: 20101111 Start Date*: 2010-09-20
    Sponsor Name:Odense University Hospital
    Full Title: Evaluation of the optimal dose of prophylactic anticoagulation with low- molecular- weight heparin administered subcutaneously to critically ill patients – part 2
    Medical condition: venous thromboembolism
    Disease: Version SOC Term Classification Code Term Level
    12.1 10049909 Venous thromboembolism prophylaxis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-006076-30 Sponsor Protocol Number: Larve 2008 Start Date*: 2009-05-28
    Sponsor Name:ASL 2 SAVONESE
    Full Title: Multicenter, randomised, open-label, parallel group, controlled study to evaluate the efficacy, tollerability and safety of BioFOAM dressing containing larve of Lucilia sericata in patients with ch...
    Medical condition: Patient with venous ulcers or mixed aetiology ulcers containig necrotic tissue
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066677 Chronic leg ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001715-36 Sponsor Protocol Number: TZP-101-CL-P005 Start Date*: 2007-07-05
    Sponsor Name:Tranzyme, Inc
    Full Title: A Multicenter, Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when Administered as a 30 Minute IV Infusion for Postoperative Ileus to ...
    Medical condition: Post Operative Ileus (POI) in subjects undergoing major open abdominal surgery
    Disease: Version SOC Term Classification Code Term Level
    9.1 10054048 Postoperative ileus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-002959-41 Sponsor Protocol Number: FLUPI-5014 Start Date*: 2005-10-10
    Sponsor Name:AWD.pharma GmbH & Co. KG; Medical Development
    Full Title: A multicentre, double-blind, randomised, placebo-controlled clinical trial to investigate pain relieving effects of the modified release (MR) formulation of flupirtine in patients suffering from mo...
    Medical condition: chronic low back pain
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-003193-14 Sponsor Protocol Number: DIAMOND Start Date*: 2017-10-03
    Sponsor Name:Department of Ophthalmology, MUW
    Full Title: Disease-modification under treatment with aflibercept in advanced diabetic retinopathy - A pilot study
    Medical condition: proliferative diabetic retinopathy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-002586-12 Sponsor Protocol Number: 1160.63 Start Date*: Information not available in EudraCT
    Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG
    Full Title: Twice-daily oral direct thrombin inhibitor dabigatran in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis or pulmonary embo...
    Medical condition: long-term prevention of recurrent symptomatic venous thromboembolism (VTE) in patients with symptomatic deep-vein thrombosis (DVT) or pulmonary embolism (PE) who completed 6 to 18 months of treatme...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10049909 Venous thromboembolism prophylaxis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) SE (Completed) AT (Completed) IT (Completed) PL (Completed) CZ (Completed) NL (Completed) BE (Completed) LT (Completed) LV (Completed) EE (Completed)
    Trial results: View results
    EudraCT Number: 2007-002631-86 Sponsor Protocol Number: 1160.46 Start Date*: 2008-10-23
    Sponsor Name:Boehringer Ingelheim Austia Gm.b.H
    Full Title: A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute sy...
    Medical condition: Acute symptomatic VTE VTE is defined as the composite incidence of Deep Vein Thrombosis of the leg (including the inferior caval vein) and Pulmonary Embolism.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037377 Pulmonary embolism LLT
    9.1 10047251 Venous thrombosis deep (limbs) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed) SK (Completed) ES (Completed) GB (Completed) NL (Completed) DK (Completed) CZ (Completed) SE (Completed) HU (Completed) FR (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2020-000280-23 Sponsor Protocol Number: BISS Start Date*: 2020-08-20
    Sponsor Name:Prof Mathias Abegg
    Full Title: A pragmatic, randomized, non-inferiority trial comparing the effectiveness of Botulinum toxin-based treatment with conventional strabismus surgery in acquired esotropia
    Medical condition: Acquired esotropia (strabismus)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004853 10015475 Esotropia LLT
    20.0 100000004853 10042163 Strabismus NOS LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-002630-11 Sponsor Protocol Number: 1160.64 Start Date*: 2008-04-07
    Sponsor Name:Boehringer Ingelheim Pharma GmbH & CoKG
    Full Title: A phase III randomised, parallel group, double-blind, active controlled study to investigate the efficacy and safety of oral 220 mg dabigatran etexilate (110 mg on the day of surgery followed by 22...
    Medical condition: Primary VTE prevention in patients following total hip replacement surgery
    Disease: Version SOC Term Classification Code Term Level
    9.1 10049909 Venous thromboembolism prophylaxis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) FI (Completed) ES (Completed) BE (Completed) DE (Completed) SE (Completed) DK (Completed) HU (Completed) CZ (Completed) AT (Completed) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 07 08:36:29 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA